There are fascinating insights into the real cost of radiotherapy in the HERO report, published today. As an effective cure for many cancers, it is CHEAP! Huge thanks to contributors, especially @katiespencer72 and @Noemiedef1
Prostate cancer cases are expected to double from 1.4 million per year in 2020 to 2.9 million per year by 2040, new analysis suggests.
More from the Lancet Commission on #ProstateCancer in-thread 🧵
▶️ https://t.co/r1VhQobHKR
If you’re a doctor looking at career paths, please consider #Oncology.
It’s an amazing & exciting field. Training is great. It’s friendly. You will get to travel the world to learn and network. Few on calls!!
Choose oncology | @RCRadiologists https://t.co/rZWDnQqZQk
They call medicine an art, not just a science
If there was one thing I would say is the most important aspect of medical training it’s this; the Dunning-Kruger
And it’s this aspect which the depth, breadth and intensity of medical school & training prepares *doctors* for 🧵
Why do some randomized controlled trials fail to influence routine radiotherapy practices? 🤔
Explore the disconnect between research findings and clinical adoption, as highlighted in Peter Hoskin's editorial https://t.co/j7BbAnDm0g
#whereishoskin#Oncology
I’m an oncologist and I love my job. But I’m striking because I know first-hand that the NHS is failing our patients with cancer and I’m striking because I know first-hand that the NHS is failing its workforce. https://t.co/Liv26cn8Or #ConsultantsStrike
This three-pager is a must-read by every oncologist. Chris Booth is one of my heroes #timetoxicity
“Thus, intensive treatments associated with more time toxicity are not incorrect choices themselves, and decisions for patients should be individualized. The most important first step is for trials to report time spent in pursuing therapy so clinicians can have meaningful discussions with patients.”
#Stupptrial #radonc #medtwitter
#STAMPEDE stops recruiting today after 18 years!
The trial's pioneering #MAMS design helped drive big improvements in #ProstateCancer survival that may have taken generations in a traditional trial.
Learn about #STAMPEDE’s impact from @MaxParmarMRCUCL & @Prof_Nick_James#STAMPEDE stops recruiting today after 18 years!
The trial's pioneering #MAMS design helped drive big improvements in #ProstateCancer survival that may have taken generations in a traditional trial.
Learn about #STAMPEDE’s impact from @MaxParmarMRCUCL & @Prof_Nick_James.
The UK Government Actuary confirms life expectancy at retirement for Britons is now two years lower than when Ministers last reviewed the state pension age in 2017.
https://t.co/1ILEbHWZcw
Bobby Caldwell R.I.P. Thank you for the music.
And thank you for making me take a long, hard look at myself when I was an early teen.
https://t.co/1SzbHmX65S
If you haven't already *please* spend 5 mins using this form to send a response to the governments pension tax consultation 👇
https://t.co/JEYAoo46FW
If you want more info please see short 🧵below (and please take a little time to personalise it)
Please do it now & share/RT!
@RTherapy4Life@grahamemorris@APPGRT Thank you for highlighting the need to increase our radiotherapy capacity. We also need to recruit, train, pay and retain staff to deliver radiation-based therapies